Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
advances in neurology
adverse drug reaction
anticonvulsants
anticonvulsants, absorption
anticonvulsants, bioavailability
anticonvulsants, blood level determination of
anticonvulsants, brand name
anticonvulsants, discontinuation in seizure-free epileptics
anticonvulsants, effectiveness
anticonvulsants, generic
anticonvulsants, parenteral administration
anticonvulsants, pharmacokinetics
anticonvulsants, selection of
anticonvulsants, subtherapeutic
anticonvulsants, untoward effects of
brand name drug
breast feeding
carbamazepine
carbamazepine, toxicity
children
clonazepam
complications
congenital birth defects
congenital malformation
counselling
dilantin
dilantin, absorption
dilantin, bioavailability
dilantin, serum level
drug interactions
epilepsy referral centers
fetus
folic acid
fosphenytoin
generic drugs
genetic counselling
lamotrigine
medical-legal aspects of neurology
mylan
mysoline
neural tube defect
phenobarbital
pregnancy, neurologic complications in
propofol
review article
seizure
seizure, children
seizure, classification of
seizure, intractable
seizure, intractable, treatment of
seizure, pregnancy
seizure, treatment of
seizure, treatment of, monotherapy
sodium valproate
spina bifida
status epilepticus
treatment of neurologic disorder
tube feeding
zarontin
Showing articles 50 to 100 of 342 << Previous Next >>

Levetiracetam in Pregnancy: Preliminary Experience From the UK Epilepsy and Pregnancy Register
Neurol 67:1876-1879, Hung,S.,et al, 2006

Practice Parameter: Diagnostic Assessment of the Child with Status Epilepticus (An Evidence-Based Review): Report of the Quality Standards Subcommittee of the American Academy of Neurology and the practice Committee of the Child Neurology Society
Neurol 67:1542-1550, Riviello,J.J. Jr.,et al, 2006

Oxcarbazepine Concentrations During Pregnancy: A Retrospective Study in Patients with Epilepsy
Neurol 67:1497-1499, Christensen,J.,et al, 2006

Phenytoin Exposure Is Associated With Functional and Cognitive Disability After Subarachnoid Hemorrhage
Stroke 36:583-587, Naidech,A., et al, 2005

Increased Rate of Major Malformations in Offspring Exposed to Valproate Durng Pregnancy
Neurol 64:961-965, 938, Wyszynski,D.F., et al, 2005

Lamotrigine and the Risk of Malformations in Pregnancy
Neurol 64:955-960, 938, Cunnington, M. , et al, 2005

Antiepileptic Drug Use of Women with Epilepsy and Congenital Malformations in Offspring
Neurol 64:1874-1878, Artama,M.,et al, 2005

Seizures Following Reduction in Phenytoin Level After Orally Administered Folic Acid
Neurol 64:1982, Steinweg,D.L.&Bentley,M.L., 2005

Differential Effects of Antiepileptic Drugs on Sexual Function and Hormones in Men with Epilepsy
Neurol 65:1016-1020,980, Herzog,A.G.,et al, 2005

Normal Intelligence in Children with Prenatal Exposure to Carbamazepine
Neurol 62:28-32,8, Gaily,E.,et al, 2004

The New Antiepileptic Drugs, Scientific Review
JAMA 291:605-614, LaRoche,S.M.&Helmers,S.L., 2004

The AED (Antiepileptic Drug) Pregnancy Registry
Arch Neurol 61:673-678, Holmes,L.B.,et al, 2004

Recreational Use of Phenytoin, Marijuana, and Alcohol: A Case Report
Neurol 62:2330, Jessen,K., 2004

Lower Phenytoin Serum Levels in Persons Switched from Brand to Generic Phenytoin
Neurol 63:1494-1496, Burkhardt,R.T.,et al, 2004

Correlating Lamotrigine Serum Concentrations with Tolerability in Patients with Epilepsy
Neurol 63:1022-1026, Hirsch,L.J.,et al, 2004

Major Malformations in Offspring of Women with Epilepsy
Neurol 60:575-579, Kaaja,E.,et al, 2003

Severe Intoxication After Phenytoin Infusion: A Preventable Pharmacogenetic Adverse Reaction
Neurol 60:1395-1396, Citerio,G.,et al, 2003

Randomized, Concentration-Controlled Trial of Topiramate in Refractory Focal Epilepsy
Neurol 61:1210-1218, Christensen,J.,et al, 2003

Subtherapeutic Free Phenytoin Levels Following Fosphenytoin Therapy in Status Epilepticus
Neurol 58:147-148, Koul,R. &Deleu,D., 2002

Valproate Embryopathy in Three Sets of Siblings: Further Proof of Hereditary Susceptibility
Neurol 59:630-633, Malm,H.,et al, 2002

The Teratogenicity of Anticonvulsant Drugs
NEJM 344:1132-1138, Holmes,L.B.,et al, 2001

Is Carbamazepine Teratogenic? A Prospective Controlled Study of 210 Pregnancies
Neurol 57:321-324, Diav-Citrin,O.,et al, 2001

Managing Status Epilepticus
BMJ 320:953-954, Heafield,M.T.E., 2000

Folic Acid Antagonists During Pregnancy and the Risk of Birth Defects
NEJM 343:1608-1614, Hernandez-Dias,S.,et al, 2000

Patients with Refractory Seizures
NEJM 340:1565-1570, Devinsky,O, 1999

Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis During First Weeks of Antiepileptic Therapy:A Case-Control Study
Lancet 353:2190-2194, Rzany,B.,et al, 1999

Phenobarbital Compared with Phenytoin for the Treatment of Neonatal Seizures
NEJM 341:485-489, Painter,M.J.,et al, 1999

Antiepileptic Drug Regimens and Major Congenital Abnormalities in the Offspring
Ann Neurol 46:739-746, Samren,E.B.,et al, 1999

Focal Lesion in the Splenium of the Corpus Callosum in Epileptic Patients:Antiepileptic Drug Toxicity
AJNR 20:125-129,131, Kim,S.S.,et al, 1999

Management Issues for Women with Epilepsy,A Review of the Literature
Neurol 51:949-956, Zahn,C.A.,et al, 1998

Analysis of Prenatal and Gestational Care Given to Women with Epilepsy
Neurol 51:1039-1045, Seale,C.G.,et al, 1998

Practice Parameter,Management Issues for Women with Epilepsy (Summary Statement)
Neurol 51:944-948, Rpt of the Quality Stnds Subcmte AAN, 1998

Incidence and Clinical Consequence of the Purple Glove Syndrome in Patients Receiving Intravenous Phenytoin
Neurol 51:1034-1039,942, O'Brien,T.J.,et al, 1998

Status Epilepticus
NEJM 338:970-976, Lowenstein,D.H.&Alldredge,B.K., 1998

Drug-Induced Pseudolymphoma Secondary to Lamotrigine
Neurol 50:1509-1510, Pathak,P.&McLachlan,R.S., 1998

Use of Anticonvul in Eclampsia & Pre-Eclampsia:Survey of Obstetr in the UK & Rep of Ireland
BMJ 316:975-976, Gulmezoglu,A.M.&Duley,L., 1998

A Comparison of Four Treatments for Generalized Convulsive Status Epilepticus
NEJM 339:792-798, Treiman,D.M.,et al, 1998

Parenteral Fosphenytoin:Efficacy and Economic Considerations
The Neurologist 4:S30-S34, Ramsay,R.E.&Wilder,B.J., 1998

Antiepileptics and Blood Dyscrasias: A Cohort Study
Pharmacotherapy 18:1277-1283, Blackburn,S.C.F.,et al, 1998

Medically Induced Gingival Hyperplasia
Mayo Clin Proc 73:1196-1199, Meraw,S.J. &Sheridan,P.J., 1998

Color Vision Test for Early Detection of Antiepileptic Drug Toxicity
Neurol 48:1394-1397, Bayer,A.U.,et al, 1997

Risk of Serious Cutaneous Disorders after Initiation of Use of Phenytoin, Carbamazepine, or Sodium Valproate
Neurol 49:542-546, Tennis,P.&Stern,R.S., 1997

Drugs and Myasthenia Gravis, An Update
Arch Int Med 157:399-408, Wittbrodt,E.T., 1997

Status Epilepticus in Children with Epilepsy:The Role of Antiepileptic Drug Levels in Prevention
Pediatrics 98:1119-1121, Maytal,J.,et al, 1996

Acute Phenytoin Toxicity Followed by Seizure Breakthrough From a Ticlopidine-Phenytoin Interaction
Arch Neurol 53:1191-1192, Privitera,M.&Welty,T.E., 1996

Safety & Toler of Multi Doses of Intramusc Fosphenytoin Substi for Oral Phenytoin in Epilep or Neurosurg
Arch Neurol 53:764-768, Wilder,B.J.,et al, 1996

Ticlopidine Impairs Phenytoin Clearance:A Case Report
Neurol 46:1172-1173, Riva,R.,et al, 1996

Random Comp Monother Trial of Phenobarb, Phenytoin, Carbamazepine, or Sod Valp for Newly Dx Child Epilep
Lancet 347:709-713, deSilva,M.,et al, 1996

A Pharmacoeconomic Eval of IV Fosphenytoin (Cerebyx) vs IV Phenytoin (Dilantin) in Hosp ER Dept
Clin Therapeutics 18:953-966, Marchetti,A.,et al, 1996

Appropriateness of Antiepileptic Drug Level Monitoring
JAMA 274:1622-1626, Schoenenbergber,R.A.,et al, 1995



Showing articles 50 to 100 of 342 << Previous Next >>